Ledger.Open graph →
SEC Form D · Amendment · filed October 15, 2014

Immunomic Therapeutics, Inc

Offering
$8.8M
Sold
$6.8M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
HERSHEY, PA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (19)

William B. Mcdonald · Monarch Beach, CADirectorRonald D. Thiboutot · Harrisburg, PADirectorMichael D. Lack · Lancaster, PADirectorTeri J. Heiland · Lancaster, PAExecBruce F. Mackler · Rockville, MDExec · DirectorJames D. Wishart · Lexington Park, MDExec · DirectorWilliam G. Hearl · Lancaster, PAExec · Director · PromoterBernard C. Rudnick · Lancaster, PAExec · DirectorMichael Solomon · New York, NYExecAnthony J. De Laurentis · Baltimore, MDDirectorTodd Carter · New York, NYExec · DirectorNathanael Clemensen · PALO ALTO, CADirectorColeman Andrews · PALO ALTO, CAExec · DirectorRmwc Credit Alpha Fund GP, LLC · PALO ALTO, CAExec · Director · PromoterRachel Markus · PALO ALTO, CADirectorMichael Rubenstein · PALO ALTO, CAExec · DirectorLaurence Wainer · Beverly Hills, CAExec · Director · PromoterGreg Schmergel · Woburn, MADirectorDave Fachetti · Woburn, MAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗